Table 2 Pathologic outcomes
All (n = 45) (%) | |
|---|---|
Tumor length (cm), mean ± SD | 12.5 ± 5.0 |
Maximum transverse | |
Diameter of tumor (cm), mean ± SD | 5.8 (range 4.5–7.8) |
Depth of tumor invasion | |
pTis | 0 |
pT1 | 0 |
pT2 | 0 |
pT3 | 5 (11.1%) |
pT4a | 37 (82.2%) |
pT4b | 3 (6.7%) |
Lymph node metastasis | |
pN0 | 0 |
pN1 | 11 (24.4%) |
pN2 | 16 (35.6%) |
pN3 | 18 (40.0%) |
M1(supraclavicular lymph nodes) | 11 (24.4%) |
Pathologic stage | |
0 | 0 |
1 | 0 |
2A | 0 |
2B | 0 |
IIIB | 19 (42.2%) |
IVA | 5 (11.1%) |
IVB | 21 (46.7%) |
Differentiation | |
G1 | 15 (33.3%) |
G2 | 30 (66.7%) |
G3 | 0 |
Gx | 0 |
R0 resection | 8 (17.7%) |
Positive CRM | 37 (82.2%) |
Cutting edge of positive anastomosis | 0 |